Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 59801-59850 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06958016
Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.
N/ARecruiting
200 participants
Started: Jan 12, 2024 · Completed: Jan 11, 2027
1 condition1 sponsor2 locations
NCT06250062
A Clinical Study of JS005 in Patients With Ankylosing Spondylitis
PHASE2Recruiting
261 participants
Started: Jan 12, 2024 · Completed: Oct 8, 2025
1 condition2 sponsors38 locations
NCT06109467
Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer
PHASE2Recruiting
36 participants
Started: Jan 12, 2024 · Completed: Apr 30, 2028
2 conditions3 sponsors1 location
NCT06241547
PONV Prevention Via Percutaneous Nerve Electrical Stimulation on PC6
PHASE2Recruiting
302 participants
Started: Jan 12, 2024 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT06907602
Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma
PHASE2/PHASE3Recruiting
120 participants
Started: Jan 12, 2024 · Completed: Dec 31, 2028
1 condition4 sponsors1 location
NCT06184737
iSIPsmarter: A Pilot RCT to Evaluate a Web-based Behavioral Intervention to Reduce Sugary Beverages Among Black Adults
NAActive, not recruiting
24 participants
Started: Jan 12, 2024 · Completed: Mar 17, 2026
2 conditions2 sponsors1 location
NCT06201598
Prospective, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Endovascular Treatment in Patients With Cerebral Aneurysms Using P64 and P48 Flow-Diverter Stents
N/ARecruiting
100 participants
Started: Jan 12, 2024 · Completed: Dec 15, 2025
2 conditions1 sponsor11 locations
NCT06223945
Thrombohemorrhagic Complications of COVID-19
NAActive, not recruiting
1 participants
Started: Jan 12, 2024 · Completed: Jan 12, 2029
1 condition1 sponsor1 location
NCT06076395
Volume Versus Pressure Ventilation on Lung Atelectasis
NAActive, not recruiting
60 participants
Started: Jan 12, 2024 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT06479759
LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE2Recruiting
50 participants
Started: Jan 12, 2024 · Completed: Dec 12, 2025
2 conditions1 sponsor1 location
NCT06059053
Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.
N/ARecruiting
100 participants
Started: Jan 12, 2024 · Completed: Mar 31, 2027
3 conditions1 sponsor1 location
NCT06075888
Metagenomic Sequencing for the Identification of Pathogens in Febrile Neutropenic Patients
NARecruiting
200 participants
Started: Jan 12, 2024 · Completed: Jan 12, 2025
1 condition2 sponsors5 locations
NCT06253325
Early Detection of At-risk Septic Patients
N/ARecruiting
60 participants
Started: Jan 12, 2024 · Completed: Aug 6, 2025
1 condition1 sponsor1 location
NCT06414317
An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers
NARecruiting
160 participants
Started: Jan 12, 2024 · Completed: Jan 1, 2026
5 conditions1 sponsor1 location
NCT06169852
Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD
NARecruiting
36 participants
Started: Jan 12, 2024 · Completed: Nov 30, 2028
1 condition2 sponsors1 location
NCT05835791
END - VT Cohort Study
N/ARecruiting
2,454 participants
Started: Jan 12, 2024 · Completed: Apr 30, 2029
3 conditions2 sponsors3 locations
NCT06267183
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
EARLY_PHASE1Recruiting
53 participants
Started: Jan 12, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06206564
Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
PHASE2Recruiting
48 participants
Started: Jan 12, 2024 · Completed: Dec 31, 2026
4 conditions3 sponsors2 locations
NCT06212323
Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
N/ARecruiting
100 participants
Started: Jan 11, 2024 · Completed: Jan 31, 2029
1 condition1 sponsor1 location
NCT06061562
Down Syndrome, Physical Activity and Sleep Apnea
N/ARecruiting
50 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06213909
Retrospective Study of the Effects of Sub-pathologic Phenotypes of BP on Clinical Management and Prognosis
N/ARecruiting
318 participants
Started: Jan 11, 2024 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05993390
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
NARecruiting
30 participants
Started: Jan 11, 2024 · Completed: Aug 30, 2025
3 conditions1 sponsor1 location
NCT06127797
Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue
N/ARecruiting
1,000 participants
Started: Jan 11, 2024 · Completed: Aug 31, 2029
1 condition1 sponsor1 location
NCT06644248
AI Model for Cervical Cancer Detection From Colposcopy Images
N/ARecruiting
500 participants
Started: Jan 11, 2024 · Completed: Feb 11, 2025
1 condition1 sponsor1 location
NCT05035342
Fecal Transplantation to Eradicate Colonizing Emergent Superbugs
PHASE3Recruiting
214 participants
Started: Jan 11, 2024 · Completed: Apr 30, 2028
2 conditions1 sponsor11 locations
NCT06077422
Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain
PHASE2/PHASE3Recruiting
120 participants
Started: Jan 11, 2024 · Completed: Apr 5, 2025
4 conditions2 sponsors1 location
NCT07004517
The Study on the Accuracy of Peri-implant Probing and Related Influencing Factors
N/ARecruiting
83 participants
Started: Jan 11, 2024 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT06564415
European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms
N/ARecruiting
2,500 participants
Started: Jan 11, 2024 · Completed: Jan 31, 2034
2 conditions1 sponsor1 location
NCT06027294
Blood Flow Regulation and Neuromuscular Function Post-Stroke
NARecruiting
40 participants
Started: Jan 11, 2024 · Completed: Jun 30, 2028
1 condition1 sponsor2 locations
NCT06391892
Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery
PHASE3Recruiting
100 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT06208215
RZ358 Treatment for Congenital Hyperinsulinism
PHASE3Recruiting
56 participants
Started: Jan 11, 2024 · Completed: Sep 28, 2026
1 condition1 sponsor24 locations
NCT06157502
Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
PHASE3Recruiting
1,380 participants
Started: Jan 11, 2024 · Completed: Jul 31, 2026
1 condition1 sponsor82 locations
NCT06469424
An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)
N/ARecruiting
104 participants
Started: Jan 11, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors5 locations
NCT06717984
AI Model for Classifying Breast Cancer From Histopathology Images
N/ARecruiting
500 participants
Started: Jan 11, 2024 · Completed: Feb 11, 2025
1 condition2 sponsors1 location
NCT06208306
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
PHASE3Active, not recruiting
700 participants
Started: Jan 11, 2024 · Completed: Dec 1, 2026
1 condition2 sponsors223 locations
NCT06259227
Cardiorespiratory Fitness Training in Patients with Incomplete Spinal Cord Injury
NARecruiting
32 participants
Started: Jan 11, 2024 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location
NCT06194981
Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage
N/ARecruiting
260 participants
Started: Jan 11, 2024 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT06418126
Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer
NARecruiting
15 participants
Started: Jan 11, 2024 · Completed: Apr 1, 2027
1 condition2 sponsors1 location
NCT06074068
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
NARecruiting
1,080 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2028
2 conditions4 sponsors2 locations
NCT05906992
A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis
PHASE3Recruiting
512 participants
Started: Jan 11, 2024 · Completed: Jan 31, 2029
1 condition1 sponsor1 location
NCT06396663
DE-eSCALation of Opioids Post-surgical dischargE
NARecruiting
100 participants
Started: Jan 11, 2024 · Completed: Sep 30, 2024
1 condition3 sponsors1 location
NCT06270199
Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.
PHASE2Recruiting
75 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor7 locations
NCT05892432
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
PHASE2Active, not recruiting
50 participants
Started: Jan 11, 2024 · Completed: Oct 30, 2025
1 condition2 sponsors1 location
NCT05573490
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
NARecruiting
60 participants
Started: Jan 11, 2024 · Completed: Jun 30, 2028
1 condition5 sponsors1 location
NCT06051227
Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial
PHASE3Recruiting
608 participants
Started: Jan 11, 2024 · Completed: Mar 31, 2026
5 conditions3 sponsors1 location
NCT06214143
A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
68 participants
Started: Jan 11, 2024 · Completed: May 31, 2026
1 condition1 sponsor22 locations
NCT06146257
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
PHASE1Recruiting
48 participants
Started: Jan 11, 2024 · Completed: Oct 8, 2026
2 conditions1 sponsor8 locations
NCT06231641
The Effects of Lemborexant on the Ability to Sleep During Daytime
PHASE2Recruiting
24 participants
Started: Jan 11, 2024 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT06220617
Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
N/ARecruiting
3,600 participants
Started: Jan 11, 2024 · Completed: Jun 30, 2027
4 conditions2 sponsors6 locations
NCT05975593
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
NARecruiting
60 participants
Started: Jan 11, 2024 · Completed: Dec 31, 2032
10 conditions2 sponsors1 location